# Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

> **NCT06926842** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Zealand Pharma** · enrollment: 221 (actual)

## Conditions studied

- Overweight
- Type 2 Diabetes
- Obesity

## Interventions

- **DRUG:** Petrelintide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06926842
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2026-08-13
- **Final completion:** 2026-08-13
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926842, "Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06926842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*